Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1996 Jan;51(1):64–70. doi: 10.1136/thx.51.1.64

Effect of endobronchial aspirin challenge on inflammatory cells in bronchial biopsy samples from aspirin-sensitive asthmatic subjects.

S Nasser 1, P E Christie 1, R Pfister 1, A R Sousa 1, A Walls 1, M Schmitz-Schumann 1, T H Lee 1
PMCID: PMC472802  PMID: 8658372

Abstract

BACKGROUND: The aspirin-induced bronchoconstriction in patients with aspirin-sensitive asthma is caused by cysteinyl leukotriene release. The cellular source of the leukotrienes is unknown. The inflammatory cell infiltrate in bronchial biopsy samples from seven aspirin-sensitive asthmatic (ASA) subjects and eight non-ASA subjects before and after local challenge with lysine aspirin was therefore examined. METHODS: Using flexible bronchoscopy, airway mucosal biopsy samples were taken and lysine aspirin solution was placed directly onto a carina of the contralateral lung. Twenty minutes later a second series of biopsy samples was taken from the site of the local endobronchial lysine aspirin challenge. The biopsy samples were double immunostained with a rabbit polyclonal antibody to the enzyme 5-lipoxygenase and monoclonal antibodies to mast cells (AA1), neutrophils (NP57), macrophages (EBM11), T lymphocytes (anti-CD3), and total (BMK13) and activated eosinophils (EG2). RESULTS: A decrease in both absolute mast cell numbers staining with mast cell tryptase (AA1) and the percentage of mast cells co-immunostaining with 5-lipoxygenase was seen in the ASA patients after lysine aspirin challenge compared with the non-ASA control group. There was also an increase in the numbers of activated eosinophils (EG2) in the ASA subjects compared with the non-ASA group. No changes were observed in the total numbers of macrophages (EBM11), neutrophils (NP57), total eosinophils (BMK13), and T lymphocytes (anti-CD3) after challenge with lysine aspirin. CONCLUSIONS: The decrease in numbers of mast cells staining for tryptase and the increase in activated eosinophils after endobronchial challenge with lysine aspirin may represent degranulation of these cell types, and may be an early event associated with aspirin-sensitive reactions in ASA subjects.

Full text

PDF
64

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrew S. M., Jasani B. An improved method for the inhibition of endogenous peroxidase non-deleterious to lymphocyte surface markers. Application to immunoperoxidase studies on eosinophil-rich tissue preparations. Histochem J. 1987 Aug;19(8):426–430. doi: 10.1007/BF01675753. [DOI] [PubMed] [Google Scholar]
  2. Bosso J. V., Schwartz L. B., Stevenson D. D. Tryptase and histamine release during aspirin-induced respiratory reactions. J Allergy Clin Immunol. 1991 Dec;88(6):830–837. doi: 10.1016/0091-6749(91)90238-j. [DOI] [PubMed] [Google Scholar]
  3. Christie P. E., Smith C. M., Lee T. H. The potent and selective sulfidopeptide leukotriene antagonist, SK&F 104353, inhibits aspirin-induced asthma. Am Rev Respir Dis. 1991 Oct;144(4):957–958. doi: 10.1164/ajrccm/144.4.957. [DOI] [PubMed] [Google Scholar]
  4. Christie P. E., Tagari P., Ford-Hutchinson A. W., Black C., Markendorf A., Schmitz-Schumann M., Lee T. H. Urinary leukotriene E4 after lysine-aspirin inhalation in asthmatic subjects. Am Rev Respir Dis. 1992 Dec;146(6):1531–1534. doi: 10.1164/ajrccm/146.6.1531. [DOI] [PubMed] [Google Scholar]
  5. Dahlén B., Kumlin M., Margolskee D. J., Larsson C., Blomqvist H., Williams V. C., Zetterström O., Dahlén S. E. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. Eur Respir J. 1993 Jul;6(7):1018–1026. [PubMed] [Google Scholar]
  6. Ferreri N. R., Howland W. C., Stevenson D. D., Spiegelberg H. L. Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. Am Rev Respir Dis. 1988 Apr;137(4):847–854. doi: 10.1164/ajrccm/137.4.847. [DOI] [PubMed] [Google Scholar]
  7. Fischer A. R., Rosenberg M. A., Lilly C. M., Callery J. C., Rubin P., Cohn J., White M. V., Igarashi Y., Kaliner M. A., Drazen J. M. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol. 1994 Dec;94(6 Pt 1):1046–1056. doi: 10.1016/0091-6749(94)90123-6. [DOI] [PubMed] [Google Scholar]
  8. Grzelewska-Rzymowska I., Szmidt M., Rozniecki J., Grzegorczyk J. Aspirin-induced neutrophil chemotactic activity (NCA) in patients with aspirin-sensitive urticaria after desensitization to the drug. J Investig Allergol Clin Immunol. 1994 Jan-Feb;4(1):28–31. [PubMed] [Google Scholar]
  9. Imokawa S., Sato A., Taniguchi M., Toyoshima M., Nakazawa K., Hayakawa H., Chida K. [Sodium cromoglycate nebulized solution has an acute bronchodilative effect in patients with aspirin-intolerant asthma (AIA)]. Arerugi. 1992 Oct;41(10):1515–1520. [PubMed] [Google Scholar]
  10. Israel E., Fischer A. R., Rosenberg M. A., Lilly C. M., Callery J. C., Shapiro J., Cohn J., Rubin P., Drazen J. M. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1447–1451. doi: 10.1164/ajrccm/148.6_Pt_1.1447. [DOI] [PubMed] [Google Scholar]
  11. Maddox P. H., Jenkins D. 3-Aminopropyltriethoxysilane (APES): a new advance in section adhesion. J Clin Pathol. 1987 Oct;40(10):1256–1257. doi: 10.1136/jcp.40.10.1256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Martelli N. A., Usandivaras G. Inhibition of aspirin-induced bronchoconstriction by sodium cromoglycate inhalation. Thorax. 1977 Dec;32(6):684–690. doi: 10.1136/thx.32.6.684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nasser S. M., Bell G. S., Foster S., Spruce K. E., MacMillan R., Williams A. J., Lee T. H., Arm J. P. Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma. Thorax. 1994 Aug;49(8):749–756. doi: 10.1136/thx.49.8.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ortolani C., Mirone C., Fontana A., Folco G. C., Miadonna A., Montalbetti N., Rinaldi M., Sala A., Tedeschi A., Valente D. Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients. Ann Allergy. 1987 Nov;59(5 Pt 2):106–112. [PubMed] [Google Scholar]
  15. Samter M., Beers R. F., Jr Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968 May;68(5):975–983. doi: 10.7326/0003-4819-68-5-975. [DOI] [PubMed] [Google Scholar]
  16. Schmitz-Schumann M., Schaub E., Virchow C. Inhalative Provokation mit Lysin-Azetylsalizylsäure bei Analgetika-Asthme-Syndrom. Prax Klin Pneumol. 1982 Jan;36(1):17–21. [PubMed] [Google Scholar]
  17. Sladek K., Dworski R., Soja J., Sheller J. R., Nizankowska E., Oates J. A., Szczeklik A. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med. 1994 Apr;149(4 Pt 1):940–946. doi: 10.1164/ajrccm.149.4.8143059. [DOI] [PubMed] [Google Scholar]
  18. Sladek K., Szczeklik A. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J. 1993 Mar;6(3):391–399. [PubMed] [Google Scholar]
  19. Woods J. W., Evans J. F., Ethier D., Scott S., Vickers P. J., Hearn L., Heibein J. A., Charleson S., Singer I. I. 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J Exp Med. 1993 Dec 1;178(6):1935–1946. doi: 10.1084/jem.178.6.1935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Yamashita T., Tsuji H., Maeda N., Tomoda K., Kumazawa T. Etiology of nasal polyps associated with aspirin-sensitive asthma. Rhinol Suppl. 1989;8:15–24. [PubMed] [Google Scholar]
  21. Yocum M. W., Butterfield J. H., Gharib H. Increased plasma calcitonin levels in systemic mast cell disease. Mayo Clin Proc. 1994 Oct;69(10):987–990. doi: 10.1016/s0025-6196(12)61825-4. [DOI] [PubMed] [Google Scholar]
  22. Yoshimi R., Takamura H., Takasaki K., Tsurumoto H., Kumagami H. [Immunohistological study of eosinophilic infiltration of nasal polyps in aspirin-induced asthma]. Nihon Jibiinkoka Gakkai Kaiho. 1993 Nov;96(11):1922–1925. doi: 10.3950/jibiinkoka.96.1922. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES